| Revenue growth | Consol Q2 +9.8% YoY; H1 +10.7% YoY |
|---|---|
| Margins | Consol EBITDA margin 14.6% vs 15.9% YoY |
| Demand visibility | Occupancy 52% vs 48%; surgeries +14.3% YoY |
Growth
Consolidated H1 FY27 revenue +10.7% to ₹6,569mn; H1 PAT +22.9% to ₹184mn, though Q2 PBT fell 13.7%.
Outlook
No numeric growth guidance; focus on arthroplasty leadership, occupancy growth, and doubling ROCE via operating leverage.
Risks
Consolidated Q2 PBT -13.7% YoY; MedTech revenue -33% QoQ; inventory ₹3,374mn; net debt ₹4,582mn.
Last quarter's promises, checked
Delivered
- Net debt 'stable or reducing' → ₹4,582mn vs ₹463cr (₹4,630mn) at Q1 (= BEAT)
Missed
- MedTech ~93% growth sustained → MedTech -6% YoY, -33% QoQ (= MISS)
- Gross margin +100–200bps/qtr → consol EBITDA margin 14.5%→14.6% QoQ, proxy (= MISS)
Investor Presentation filed with BSE, NSE: SHALBY. Summary written with AI assistance from the document.
Shalby Ltd: key numbers
- Share price
- ₹123.06
- Market cap
- ₹1,329 Cr
- Revenue (annual)
- ₹1,141 Cr
- Net profit (annual)
- ₹37.39 Cr
- P/E (TTM)
- 33.8×Sector 53.7×
- Promoter holding
- 74.33%+0.00% QoQ
- FII holding
- 4.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shalby Ltd
All →Shalby Annual General Meeting
Shalby Ltd seeks shareholder approval via postal ballot to appoint Shanay Vikram Shah and Tushar Shah as directors. E-voting runs November 5 to December 4, 2026.
Shalby Management Change
Shalby Limited appointed Mr. Tushar Shah as Executive Director for five years, effective November 3, 2026, subject to shareholder approval. The change is a senior management appointment.
- Execution
- 5 years from November 3, 2026
Shalby Q2 FY27 Results: Net Profit ₹7.9 Cr, Up 8.2% YoY
Shalby Ltd reported revenue from operations of ₹313.2 Cr (+9.7% YoY) and net profit of ₹7.9 Cr (+8.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7.9 Cr · +8.2% YoY
Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Shalby Board Meeting Date
Shalby Limited has scheduled a board meeting for November 3, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Shalby Other Announcement
Shalby Ltd filed its quarterly shareholding pattern as of September 30, 2026, disclosing the promoter and public shareholding structure in compliance with SEBI regulations.